Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist (Q71102834)
Jump to navigation
Jump to search
scientific article published on 01 June 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist |
scientific article published on 01 June 1996 |
Statements
Endothelin-1 is involved in norepinephrine-induced ventricular hypertrophy in vivo. Acute effects of bosentan, an orally active, mixed endothelin ETA and ETB receptor antagonist (English)
S Kaddoura
J D Firth
K R Boheler
P H Sugden
P A Poole-Wilson